ImmuCell Corporation (ICCC)
NASDAQ: ICCC · Real-Time Price · USD
6.44
+0.09 (1.42%)
At close: Apr 2, 2026, 4:00 PM EDT
6.57
+0.13 (2.02%)
After-hours: Apr 2, 2026, 4:45 PM EDT

ImmuCell Revenue

In the year 2025, ImmuCell had annual revenue of $27.64M with 4.34% growth. ImmuCell had revenue of $7.63M in the quarter ending December 31, 2025, a decrease of -1.61%.

Revenue (ttm)
$27.64M
Revenue Growth
+4.34%
P/S Ratio
2.11
Revenue / Employee
$329,097
Employees
84
Market Cap
58.26M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202527.64M1.15M4.34%
Dec 31, 202426.49M9.02M51.64%
Dec 31, 202317.47M-1.10M-5.90%
Dec 31, 202218.57M-675.01K-3.51%
Dec 31, 202119.24M3.90M25.43%
Dec 31, 202015.34M1.62M11.80%
Dec 31, 201913.72M2.74M24.91%
Dec 31, 201810.99M555.21K5.32%
Dec 31, 201710.43M887.13K9.30%
Dec 31, 20169.54M-684.73K-6.69%
Dec 31, 201510.23M2.63M34.64%
Dec 31, 20147.60M1.59M26.46%
Dec 31, 20136.01M617.24K11.45%
Dec 31, 20125.39M278.79K5.45%
Dec 31, 20115.11M724.95K16.53%
Dec 31, 20104.39M-119.56K-2.65%
Dec 31, 20094.51M-122.55K-2.65%
Dec 31, 20084.63M-6.21M-57.31%
Dec 31, 200710.84M1.73M19.04%
Dec 31, 20069.11M-109.26K-1.19%
Dec 31, 20059.22M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
MindWalk Holdings20.70M
TScan Therapeutics10.33M
ImageneBio800.00K
Entera Bio42.00K
Impact BioMedical32.00K
Revenue Rankings